Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis
Condition: Psoriasis Vulgaris Interventions: Drug: 0.01% Halobetasol; Drug: 0.045% Tazarotene; Drug: 0.05% Clobetasol Propionate Sponsor: Dermatology Consulting Services, PLLC Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials